Regarding: "the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer". [PDF]
Li D, Sun C, Wang C.
europepmc +1 more source
Tumor markers level profile in dermatomyositis, systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and ovarian cancer. [PDF]
Cai JC +7 more
europepmc +1 more source
A dual-signal-amplified electrochemical biosensor for sensitive and accurate detection of cancer cells. [PDF]
Wu Y, Wang Y, He R, Li Y, Ben Y.
europepmc +1 more source
Role of <sup>18</sup>F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma. [PDF]
Pu Y +11 more
europepmc +1 more source
The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer. [PDF]
Ma Y +6 more
europepmc +1 more source
Male occult breast cancer with features highly resembling primary lung cancer: a case report and literature review. [PDF]
Su H +6 more
europepmc +1 more source
Plasma assay of methylated DNA markers detects recurrent metastatic breast cancer. [PDF]
Giridhar KV +18 more
europepmc +1 more source
Elevated tumour markers in the pleural effusion of a patient with spontaneous esophageal rupture: a rare case report. [PDF]
Liang H, Li X, Wei Z.
europepmc +1 more source
Efficacy and safety of anlotinib hydrochloride combined with concurrent radiotherapy in the treatment of locally advanced cervical cancer: a single-arm, single-center, exploratory, phase II clinical study. [PDF]
Liu H +7 more
europepmc +1 more source

